Tyler Menichiello on Muck Rack

Tyler Menichiello

Verified
(He/Him)
Pittsburgh
As seen in: Bioprocess Online, Cell & Gene, Life Science Connect, Clinical Leader, Life Science Leader, Pharmaceutical Online, Outsourced Pharma, Advancing RNA
Covers:  Biopharmaceutical development and manufacturing, including R&D, CMC, analytical development, process development, and regulatory updates
Doesn't Cover: Small molecule (traditional pharmaceutical) development or manufacturing, academic research, clinical data, or drug discovery

Get in touch with Tyler

Contact Tyler, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Tyler Menichiello’s Biography

Read Full Bio →

Tyler Menichiello is chief editor at Bioprocess Online, a trade publication for the biopharmaceutical industry. He interviews biotech executives and subject matter experts about their most pressing challenges in order to deliver actionable insights for biologics developers and manufacturers. Previously, he spent two years as a clinical research associate at the University of Pittsburgh Medical Center’s (UPMC) Hillman Cancer Center, working on clinical trials for hematological malignancies. He s…

Articles

Essential CMC Elements For A Therapeutic Secretome

|
By Tyler Menichiello Verified
| Bioprocess Online Verified
By Tyler Menichiello, Chief Editor, Bioprocess Online I attended Life Sciences Future SW earlier this year, a local industry event put together by the Pittsburgh Life Sciences Alliance (PLSA) and Life Sciences Pennsylvania (LSPA) to unite stakeholders across the region. It was during this event that I first heard about Noveome Biotherapeutics, a Pittsburgh-based biotech company pioneering a first-of-its-kind secretome therapy.
Open in Who Shared Issue with article?

06.22.26 -- On The Ground At NextGen Biomed 2026

|
By Tyler Menichiello Verified
| Bioprocess Online Verified
Microbial Services: Your CDMO Partner For Life Microbial bioproduction demands speed, reliability, and deep process understanding to move complex molecules from early development to commercial manufacturing. A modular, flexible approach enables programs to progress efficiently while managing risk across every stage of the lifecycle. Extensive experience with common microbial hosts—including E.
Open in Who Shared Issue with article?

Midyear Pulse Check: What's Shaping Biopharma In 2026?

|
By Tyler Menichiello Verified
| Bioprocess Online Verified
By Tyler Menichiello, Chief Editor, Bioprocess Online It’s that time of the year when industry outlooks start getting measured against reality. In that spirit, I gathered my fellow editors from across the Life Science Connect ecosystem to join me on a special episode of the “Better Biopharma” podcast for a midyear check-in and editorial roundtable.
Open in Who Shared Issue with article?
See all 208 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified